EMA Seeking Input on Clinical Data Transparency Proposals

Clinical Trials Advisor
A A
The European Medicines Agency appears to be backing off promises to protect industry trade secrets in its new clinical trials database, and is developing scenarios under which it would release commercially confidential information.

To View This Article:

Login

Subscribe To Clinical Trials Advisor